![](/img/cover-not-exists.png)
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group
M. Feuring-Buske, M. Kneba, M. Unterhalt, A. Engert, M. Gramatzki, E. Hiller, L. Trümper, W. Brugger, H. Ostermann, J. Atzpodien, M. Hallek, E. Aulitzky, W. HiddemannVolume:
79
Language:
english
Pages:
8
DOI:
10.1007/s002770000163
Date:
September, 2000
File:
PDF, 90 KB
english, 2000